Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANHELTO 2: Olodaterol and Tiotropium in COPD
NCT01696058Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Sep 2012; status: completed.
02
Drugs
olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01696058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696058.